DK2091919T3 - Derivater af 18-amino-substituerede analoge af geldamycinhydroquinon med cytotoksisk aktivitet til behandling af cancer - Google Patents

Derivater af 18-amino-substituerede analoge af geldamycinhydroquinon med cytotoksisk aktivitet til behandling af cancer

Info

Publication number
DK2091919T3
DK2091919T3 DK07854639.7T DK07854639T DK2091919T3 DK 2091919 T3 DK2091919 T3 DK 2091919T3 DK 07854639 T DK07854639 T DK 07854639T DK 2091919 T3 DK2091919 T3 DK 2091919T3
Authority
DK
Denmark
Prior art keywords
geldamycin
hydroquinone
cancer
derivatives
amino
Prior art date
Application number
DK07854639.7T
Other languages
English (en)
Inventor
Chunlin Tao
Hongna Han
Xiaowen Sun
Neil Desai
Patrick Soon-Shiong
Original Assignee
Abraxis Bioscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abraxis Bioscience Llc filed Critical Abraxis Bioscience Llc
Application granted granted Critical
Publication of DK2091919T3 publication Critical patent/DK2091919T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK07854639.7T 2006-11-15 2007-11-14 Derivater af 18-amino-substituerede analoge af geldamycinhydroquinon med cytotoksisk aktivitet til behandling af cancer DK2091919T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86597706P 2006-11-15 2006-11-15
PCT/US2007/084662 WO2008061134A1 (en) 2006-11-15 2007-11-14 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer

Publications (1)

Publication Number Publication Date
DK2091919T3 true DK2091919T3 (da) 2011-12-05

Family

ID=39106113

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07854639.7T DK2091919T3 (da) 2006-11-15 2007-11-14 Derivater af 18-amino-substituerede analoge af geldamycinhydroquinon med cytotoksisk aktivitet til behandling af cancer

Country Status (11)

Country Link
US (1) US7816346B2 (da)
EP (1) EP2091919B1 (da)
AT (1) ATE520666T1 (da)
CA (1) CA2669820A1 (da)
CY (1) CY1112755T1 (da)
DK (1) DK2091919T3 (da)
ES (1) ES2367876T3 (da)
PL (1) PL2091919T3 (da)
PT (1) PT2091919E (da)
SI (1) SI2091919T1 (da)
WO (1) WO2008061134A1 (da)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987035A (en) * 1974-04-05 1976-10-19 University Of Illinois Foundation Biologically active compounds
EP0664702A1 (en) * 1992-10-14 1995-08-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies
US6537579B1 (en) * 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents

Also Published As

Publication number Publication date
EP2091919B1 (en) 2011-08-17
WO2008061134A1 (en) 2008-05-22
PT2091919E (pt) 2011-09-05
US20080234246A1 (en) 2008-09-25
ATE520666T1 (de) 2011-09-15
US7816346B2 (en) 2010-10-19
ES2367876T3 (es) 2011-11-10
EP2091919A1 (en) 2009-08-26
CY1112755T1 (el) 2016-02-10
SI2091919T1 (sl) 2011-12-30
CA2669820A1 (en) 2008-05-22
PL2091919T3 (pl) 2011-12-30

Similar Documents

Publication Publication Date Title
NO2020031I1 (no) kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
MY159955A (en) Certain chemical entities, compositions and methods
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
UA109878C2 (uk) Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти)
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
NO20073065L (no) Injiserbare nanopartikulaere olanzapinformuleringer
UA118645C2 (uk) Спосіб комбінованої терапії раку наночастинками, що містять рапаміцин і альбумін
NO20090623L (no) Forbindelser for behandling av proliferative lidelser
EA201000016A1 (ru) Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
CL2008002243A1 (es) Compuestos derivados de 2-pirazolamino-1,3,5-triazina, inhibidores de kinasa jak; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del cancer.
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
ATE493418T1 (de) Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren
DK2054418T3 (da) Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
CL2009000949A1 (es) Compuestos derivados de 1,2,3,5-tetrahidro-indolizina, 6,7,8,9-tetrahidro-4h-quinolizina sustituidos, inhibidores de la actividad de cinasa de mek; su composicion farmaceutica; su uso para el tratamiento de enfermedades hiperproliferativas, tal como cancer e inflamaciones.
EP2099458A4 (en) COMPOUNDS AND METHODS FOR IMAGING AND THERAPY OF ENZYME-MEDIATED TUMORS
EP2124554A4 (en) COMPOSITIONS AND METHODS FOR CANCER TREATMENT
DK2091919T3 (da) Derivater af 18-amino-substituerede analoge af geldamycinhydroquinon med cytotoksisk aktivitet til behandling af cancer
DK1962822T3 (da) Terapi af maligne neoplasier
UA96742C2 (en) Mek inhibitors and use thereof
EA201990219A3 (ru) Ингибиторы mek и способы их применения